These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 930174)

  • 1. [Pathogenetic relationships between obesity and maturity-onset diabetes].
    Spanár E; Uhrín P; Levcík A; Záhradný V
    Z Gesamte Inn Med; 1977 Jun; 32(11):suppl 170-1. PubMed ID: 930174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
    J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intensified therapy of newly detected maturity onset diabetes].
    Pissarek D; Panzram G; Lundershausen R; Adolph W; Senf L
    Endokrinologie; 1980 Jan; 75(1):105-15. PubMed ID: 6989592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].
    Lisch HJ; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1980 Apr; 92(8):266-9. PubMed ID: 6996339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overweight and increased diabetes susceptibility in neonatally insulin-treated adult rats.
    Harder T; Rake A; Rohde W; Doerner G; Plagemann A
    Endocr Regul; 1999 Mar; 33(1):25-31. PubMed ID: 10200585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term tolbutamide treatment on insulin dynamics in newly diagnosed obese and non-obese adult diabetics.
    Wajchenberg BL; Nakasone K; Pasternak K
    Horm Metab Res; 1970 Jan; 2(1):6-8. PubMed ID: 5520756
    [No Abstract]   [Full Text] [Related]  

  • 10. The natural history of diabetes mellitus.
    Rosenbloom AL
    J Fla Med Assoc; 1971 May; 58(5):31-4. PubMed ID: 5573444
    [No Abstract]   [Full Text] [Related]  

  • 11. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in the therapy of diabetes].
    Raptis S; Rothenbuchner G; Pfeiffer EF
    Wien Med Wochenschr; 1971 Apr; 121(14):261-9. PubMed ID: 5559791
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of long-term biguanide therapy as a preventive measure in protodiabetes].
    Neumann VI; Michaelis D; Schulz B; Wulfert P; Heinke P
    Endokrinologie; 1975 Feb; 64(3):290-8. PubMed ID: 1227826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results in diabetic therapy with Silubin retard. 3].
    Kopp H
    Med Klin; 1971 Feb; 66(7):246-7. PubMed ID: 5552720
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radioimmunological determination of insulin in patients with manifest diabetes mellitus as a guide for the planning of therapy (author's transl)].
    Zilker T; Kränzlin T; Schweigart U; Ermler R; Bottermann P
    Med Klin; 1976 Apr; 71(18):761-7. PubMed ID: 818495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the effect of insulin on carbohydrate and lipid metabolism in obese subjects with normal glucose tolerance].
    Ratzmann VK; Wittig M; Krause G; Männchen E
    Z Gesamte Inn Med; 1975 Aug; 30(15):489-94. PubMed ID: 1189493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum prolactin in obese subjects with glucose intolerance before and after treatment with phenformin].
    Pata P; Smedile G; Morabito S; Mancuso TR; Arcoraci A
    Boll Soc Ital Biol Sper; 1981 Mar; 57(5):522-5. PubMed ID: 7020721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.